Performance of decision algorithms for the identification of low bone mineral density 314 in Portuguese postmenopausal women;Desempenho de algoritmos de avaliação do risco osteoporótico em mulheres pós-menopáusicas portuguesas

Acta Reumatologica Portuguesa

Volumn 33, Issue 3, 2008, Pages 314-328

  Machado, Pedro ^a   da Silva, José António Pereira ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Cost effectiveness; Densitometry; Osteoporosis; Postmenopausal women; Screening

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BONE DENSITY; COMPARATIVE STUDY; COST; ECONOMICS; FEMALE; HUMAN; MIDDLE AGED; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PORTUGAL; POSTMENOPAUSE;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BONE DENSITY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PORTUGAL; POSTMENOPAUSE;

EID: 58849129882     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Epstein S. Postmenopausal osteoporosis: fracture consequences and treatment efficacy vary by skeletal site. Aging (Milano) 2000;12:330-341.
2. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-882.
3. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-528.
4. Lewiecki EM, Watts NB, McClung MR et al. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 2004;89:3651-3655.
5. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194:3-11.
6. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005;353:164-171.
7. Solomon DH, Levin E, Helfgott SM. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment. J Rheumatol 2000;27:1496-1500.
8. Bates DW, Black DM, Cummings SR. Clinical use of bone densitometry: clinical applications. Jama 2002;288:1898-1900.
9. Weinstein L, Ullery B. Identification of at-risk women for osteoporosis screening. Am J Obstet Gynecol 2000;183:547-549.
10. Michaelsson K, Bergstrom R, Mallmin H, Holmberg L, Wolk A, Ljunghall S. Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int 1996;6:120-126.
11. Cadarette SM, Jaglal SB, Murray TM. Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry. Osteoporos Int 1999;10:85-90.
12. Koh LK, Sedrine WB, Torralba TP et al. A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int 2001;12:699-705.
13. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. Cmaj 2000;162:1289-1294.
14. Geusens P, Hochberg MC, van der Voort DJ et al. Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc 2002;77:629-637.
15. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998;4:37-48.
16. Sedrine WB, Chevallier T, Zegels B et al. Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecol Endocrinol 2002;16:245-250.
17. Salaffi F, Silveri F, Stancati A et al. An assessment tool for predicting fracture risk in postmenopausal women. Development and validation of the ORACLE score to predict risk of osteoporosis. Clin Rheumatol 2001;12:519-528.
18. Black DM, Steinbuch M, Palermo L et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001;12:519-528.
19. Salaffi F, Silveri F, Stancati A, Grassi W. Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol 2005;24:203-211.
20. Cadarette SM, McIsaac WJ, Hawker GA et al. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int 2004;15:361-366.
21. Tavares V, Canhao H, Gomes JA et al. Recommendations for the diagnosis and management of osteoporosis. Acta Reumatol Port 2007;32:49-59.
22. Kanis JA, Black D, Cooper C et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 2002;13:527-536.
23. Leib ES, Binkley N, Bilezikian JP, Kendler DL, Lewiecki EM, Petak SM. Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005. J Rheumatol 2006;33:2319-2321.
24. Gourlay ML, Miller WC, Richy F, Garrett JM, Hanson LC, Reginster JY. Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years. Osteoporos Int 2005;16:921-927.
25. Rud B, Jensen JE, Mosekilde L, Nielsen SP, Hilden J, Abrahamsen B. Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry. Osteoporos Int 2005;16:764-772.
26. Chan SP, Teo CC, Ng SA, Goh N, Tan C, Deurenberg-Yap M. Validation of various osteoporosis risk indices in elderly Chinese females in Singapore. Osteoporos Int 2006;17:1182-1188.
27. Martinez-Aguila D, Gomez-Vaquero C, Rozadilla A, Romera M, Narvaez J, Nolla JM. Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit. J Rheumatol 2007;34:1307-1312.
28. Fujiwara S, Masunari N, Suzuki G, Ross P. Performance of osteoporosis risk indices in a Japanese population. Curr Ther Res 2001;62:586-94.
29. da Silva JAP, Carapito H, Reis P. Bone densitometry: diagnostic criteria in the Portuguese population. Acta Reumatol Port 1999;93:9-18.
30. Looker AC, Wahner HW, Dunn WL et al. Proximal femur bone mineral levels of US adults. Osteoporos Int 1995;5:389-409.
31. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-13.
32. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981;94:557-592.
33. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001;12:989-995.
34. Kanis JA, Borgstrom F, De Laet C et al. Assessment of fracture risk. Osteoporos Int 2005;16:581-589.
35. Mausner J KS. Epidemiology. An Introductory Text. Second ed. Philadelphia: W. B. Saunders Company; 1984.
36. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002;288:321-333.
37. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med 2005;142:855-860.
38. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:529-541.
39. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Cmaj 2002;167:1-34.
40. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. Jama 2000;284:79-84.